DRADS Capital

Alsym Energy is a developer of innovative rechargeable energy storage technology that is free of lithium and cobalt, positioning itself as a sustainable alternative in the energy market. The company's technology is designed for a variety of applications, including stationary storage, maritime shipping, and electric vehicles. By utilizing readily available, non-toxic, and non-flammable materials, Alsym Energy aims to provide high-performance energy storage solutions at a significantly lower cost compared to traditional lithium-ion systems. This approach not only enhances the efficiency of energy storage but also accelerates the decarbonization process, making it a crucial player in the transition to cleaner energy sources worldwide.

QuanticAsset develops AI-driven asset management and investment products for high-net-worth family offices and institutional investors.

Angiowave Provides shockwave therapy services intended to offer safe, comfortable treatment for men to optimize sexual performance.

The Live Green Company, founded in 2018 and headquartered in Santiago, Chile, specializes in the development of plant-based food products. The company offers a range of items, including live green burger mixes and live green pancake mixes. Utilizing proprietary deep technology, The Live Green Company focuses on creating consumer packaged goods that are functional, clean, and sustainable. Their innovative approach incorporates artificial intelligence, machine learning, and precision fermentation to enhance research and development processes, allowing for the efficient creation of active functional ingredients. The Live Green Company is committed to promoting a healthier and more sustainable food future.

The Live Green Company, founded in 2018 and headquartered in Santiago, Chile, specializes in the development of plant-based food products. The company offers a range of items, including live green burger mixes and live green pancake mixes. Utilizing proprietary deep technology, The Live Green Company focuses on creating consumer packaged goods that are functional, clean, and sustainable. Their innovative approach incorporates artificial intelligence, machine learning, and precision fermentation to enhance research and development processes, allowing for the efficient creation of active functional ingredients. The Live Green Company is committed to promoting a healthier and more sustainable food future.

Hyperfine is a pioneering medical device company known for developing Swoop, the first FDA-cleared point-of-care MRI system. Swoop is designed to enhance patient access to rapid diagnosis and treatment, regardless of socioeconomic factors or geographic location. This innovative portable MRI system operates at a lower magnetic field strength than traditional MRI machines, allowing for high-quality imaging in a variety of clinical environments. Swoop can be easily transported to a patient's bedside, requires only a standard electrical outlet, and is controlled via an iPad, facilitating quick scans that support critical decision-making in settings such as emergency departments and intensive care units. Hyperfine generates revenue through the sale of its MRI devices as well as service sales, which include subscriptions for bundled devices, maintenance, and software.

Zammo.ai is a developer of a conversational artificial intelligence platform designed to enhance customer engagement and improve accessibility for enterprises globally. By streamlining the creation of interactive experiences akin to ChatGPT, Zammo enables businesses to utilize their web pages, knowledge base articles, and document repositories across various communication channels, including voice, text, Telephony, and social media, in multiple languages. The platform is user-friendly, affordable, and requires minimal IT assistance, allowing organizations of all sizes to establish a branded presence and deploy conversational AI solutions swiftly. Zammo not only facilitates digital transformation for enterprises but also prioritizes accessibility, empowering individuals with disabilities to interact with businesses in more inclusive ways. As a remote team dedicated to continuous improvement, Zammo.ai strives to enhance product offerings and support the success of its clients through innovative customer engagement solutions.

MarvelBiome, Inc. is a biopharmaceutical company based in Woburn, Massachusetts, established in 2019. The company specializes in harnessing the potential of microbes to develop treatments for various human diseases. It focuses on isolating, identifying, and characterizing microbial populations to create novel therapeutic applications. Through its innovative approach, MarvelBiome aims to advance biopharmaceutical technology and support researchers in developing effective assay methods for microbial therapies.

ROKIT Healthcare specializes in the development and application of advanced 3D bioprinting technology. They offer custom hardware, software, and support services, focusing on the design and creation of personalized medical solutions. The company's core expertise lies in regenerating skin and cartilage organs using artificial intelligence and proprietary bio-fabrication techniques, aiming to improve patient outcomes through innovative surgical procedures.

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s disease, and Wolfram syndrome. Founded in 2013 and based in Cambridge, Massachusetts, the company is best known for its investigational therapy AMX0035, a fixed-dose co-formulation of sodium phenylbutyrate and Taurursodiol. This treatment aims to address the energy crisis within mitochondria and the accumulation of toxic, unfolded proteins in the endoplasmic reticulum, both of which contribute to the progression of neurodegenerative conditions. Through its research and development efforts, Amylyx seeks to provide effective solutions to mitigate the suffering caused by these debilitating diseases.

AZTherapies, Inc. is a biopharmaceutical company based in Boston, Massachusetts, focused on discovering, developing, and commercializing innovative therapies for neurodegenerative diseases, including Alzheimer's, stroke, ALS, and Parkinson's disease. Established in 2011, the company is advancing a clinical-stage pipeline of small molecule drugs designed to address the underlying mechanisms of these conditions, particularly neuroinflammation and the aggregation of amyloid-beta proteins. Its lead candidate, ALZT-OP1, employs a multi-modal approach to potentially halt or slow the progression of Alzheimer's disease, with the Phase 3 COGNITE trial fully enrolled. In addition to Alzheimer's, AZTherapies is also progressing treatments for cognitive impairment following strokes and other related disorders, aiming to enhance the quality of life for aging populations with limited therapeutic options.

REACT Neuro is a Cambridge, Massachusetts-based company focused on improving brain health through an artificial intelligence-driven digital healthcare platform. The platform offers a range of services, including eye-tracking, voice recognition, and assessments of head and body movements, all through personalized virtual reality experiences. By utilizing scientifically validated exams, REACT Neuro quantifies brain health and develops digital biomarkers, specifically designed for multimodal neurophysiological phenotyping, which aids in understanding the aging brain's health. This approach enables patients to monitor their cognitive wellness objectively and supports informed decisions regarding healthy aging.

Predictus BioSciences, Inc. was incorporated in 2010 and is based in West Roxbury, Massachusetts.